Literature DB >> 6308704

RO5-4864, a ligand for benzodiazepine micromolar and peripheral binding sites: antagonism and enhancement of behavioural effects.

S E File, S Pellow.   

Abstract

RO5-4864, a ligand for both the peripheral and for the central nervous system micromolar benzodiazepine binding sites, was investigated in the holeboard, alone and in combination with several other drugs. RO5-4864 alone caused a marked reduction in rears and motor activity and reduced head-dipping when objects were placed under the holes. All these reductions were enhanced by picrotoxin (2 and 4 mg/kg) and by CGS 8216 (3 mg/kg). RO15-1788 (10 mg/kg) reversed the reduction in rears and PK11195 (30 mg/kg), a putative antagonist for the peripheral binding site, reversed the reduction in head-dipping. The results are discussed in terms of the various benzodiazepine binding sites and possible non-specific drug effects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308704     DOI: 10.1007/bf00427962

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  High densities of benzodiazepine receptors in human cortical areas.

Authors:  C Braestrup; R Albrechtsen; R F Squires
Journal:  Nature       Date:  1977-10-20       Impact factor: 49.962

2.  Benzodiazepine receptors in rat brain.

Authors:  R F Squires; C Brastrup
Journal:  Nature       Date:  1977-04-21       Impact factor: 49.962

3.  Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.

Authors:  C Braestrup; R F Squires
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

4.  The behavioural effects of lorazepam are poorly related to its concentration in the brain.

Authors:  R G Lister; S E File; D J Greenblatt
Journal:  Life Sci       Date:  1983-04-25       Impact factor: 5.037

5.  Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864.

Authors:  P J Marangos; J Patel; J P Boulenger; R Clark-Rosenberg
Journal:  Mol Pharmacol       Date:  1982-07       Impact factor: 4.436

6.  The anxiogenic action of Ro 5-4864 is reversed by phenytoin.

Authors:  S E File; R G Lister
Journal:  Neurosci Lett       Date:  1983-01-31       Impact factor: 3.046

7.  CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist.

Authors:  A J Czernik; B Petrack; H J Kalinsky; S Psychoyos; W D Cash; C Tsai; R K Rinehart; F R Granat; R A Lovell; D E Brundish; R Wade
Journal:  Life Sci       Date:  1982-01-25       Impact factor: 5.037

8.  Micromolar affinity benzodiazepine receptors: identification and characterization in central nervous system.

Authors:  A C Bowling; R J DeLorenzo
Journal:  Science       Date:  1982-06-11       Impact factor: 47.728

9.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

10.  Benzodiazepine inhibition of the calcium-calmodulin protein kinase system in brain membrane.

Authors:  R J DeLorenzo; S Burdette; J Holderness
Journal:  Science       Date:  1981-07-31       Impact factor: 47.728

View more
  11 in total

1.  Modulatory effect of alpha 2 adrenoceptor agonists on Ro 5-4864-induced convulsions in rats and mice.

Authors:  J Kunchandy; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 3.  Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations.

Authors:  S Pellow; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  The anxiogenic action of RO 5-4864 in the social interaction test: effect of chlordiazepoxide, RO 15-1788 and CGS 8216.

Authors:  S E File; S Pellow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

5.  The peripheral benzodiazepine receptor ligand Ro 5-4864 induces supraspinal convulsions in rabbits. Reversal by the central benzodiazepine antagonist Ro 15-1788.

Authors:  M Massotti; D Lucantoni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain.

Authors:  S E File; A R Green; D J Nutt; N D Vincent
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands.

Authors:  R J Rodgers; J I Randall
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 8.  The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes.

Authors:  Calina Betlazar; Ryan J Middleton; Richard Banati; Guo-Jun Liu
Journal:  Cells       Date:  2020-02-24       Impact factor: 6.600

9.  Modulation of intracellular Ca2+ signalling in HeLa cells by the apoptotic cell death enhancer PK11195.

Authors:  Michelangelo Campanella; Gyorgy Szabadkai; Rosario Rizzuto
Journal:  Biochem Pharmacol       Date:  2008-10-04       Impact factor: 5.858

10.  NIH workshop on clinical translation of molecular imaging probes and technology--meeting report.

Authors:  Christina H Liu; Antonio Sastre; Richard Conroy; Belinda Seto; Roderic I Pettigrew
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.